Published in
Ferrata Storti Foundation, Haematologica, 5(104), p. 993-1003, 2018
DOI: 10.3324/haematol.2018.205096
Links
Tools
Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma
Journal article published in 2018 by
Adrienne A. Phillips,
Paul A. Fields,
Olivier Hermine,
Juan C. Ramos,
Brady E. Beltran,
Juliana Pereira 
,
Farooq Wandroo,
Tatyana Feldman,
Graham P. Taylor,
Ahmed Sawas,
Jeffrey Humphrey,
Michael Kurman,
Junji Moriya,
Karen Dwyer,
Mollie Leoni
and other authors.
,
Farooq Wandroo,
Tatyana Feldman,
Graham P. Taylor,
Ahmed Sawas,
Jeffrey Humphrey,
Michael Kurman,
Junji Moriya,
Karen Dwyer,
Mollie Leoni
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 